<div><div></div><div>AIM ImmunoTech initiated a warrant exercise inducement expected to generate approximately $4.2 million in gross proceeds if all eligible warrants are exercised. Holders that participate will pay a reduced $0.48 per share and receive new Class H warrants equal to 200% of the exercised shares, priced at $0.60 with a five-year term starting on stockholder approval. The company also engaged Ladenburg Thalmann as placement agent, agreeing to an 8.0% fee on proceeds, a 0.75% management fee, expense reimbursement up to $50,000, and placement agent warrants for 6% of exercised shares at $0.60. AIM plans to use net proceeds for working capital and general corporate purposes and will seek stockholder approval for issuance of the inducement warrant shares.Agreement 1: AIM ImmunoTech Launches Warrant Exercise Inducement to Raise Up to $4.2 Million<ul><li>Agreement type: Warrant exercise inducement letter and issuance of Class H warrants</li><li>Counterparty: Warrant holders</li><li>Signed / Effective: May 07 2026 / May 08 2026</li><li>Duration / Termination: 5 years for Inducement Warrants</li><li>Reason: Unlock cash from existing warrants and strengthen liquidity</li></ul>Agreement 2: AIM ImmunoTech Engages Ladenburg Thalmann as Placement Agent for Warrant Inducement<ul><li>Agreement type: Placement agent engagement for warrant inducement</li><li>Counterparty: Ladenburg Thalmann</li><li>Signed / Effective: May 07 2026 / May 08 2026</li><li>Duration / Termination: At will</li><li>Reason: Facilitate holder participation and manage offering logistics</li></ul>Original SEC Filing: AIM ImmunoTech Inc. [ AIM ] - 8-K - May. 08, 2026<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

ARKG

AIM ImmunoTech has launched a warrant exercise inducement expected to raise approximately $4.2 million if all eligible warrants are exercised. Participants will pay $0.48 per share and receive new Class H warrants at $0.60. The company has engaged Ladenburg Thalmann as a placement agent, agreeing to an 8.0% fee on proceeds and other terms. The net proceeds will be used for working capital and general corporate purposes, pending stockholder approval for the issuance of the inducement warrant shares.

TradingView

AIM ImmunoTech

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

Invesco Nasdaq Biotechnology ETF

SPDR S&P Biotech

ALPS Medical Breakthrough

iShares Biotechnology ETF

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

AIM IMMUNOTECH INC

AIM ImmunoTech Inc.

AIM ImmunoTech Launches Warrant Inducement; Expects ~$4.2 Million, Hires Ladenburg Thalmann